• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (4)
    • Angiotensin-neprilysin inhibition versus enalapril in heart failure.
    • Associations between coping, diabetes knowledge, medication adherence and self-care behaviors in adults with type 2 diabetes.
    • Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment.
    • Increased severity of alcohol withdrawal in in-patient alcoholics with a co-existing anxiety diagnosis.
    • See All 4 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014 Sep 11; 371(11):993-1004.

View in: PubMed

subject areas
  • Aged
  • Aminobutyrates
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Biphenyl Compounds
  • Double-Blind Method
  • Drug Combinations
  • Enalapril
  • Female
  • Heart Failure
  • Hospitalization
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neprilysin
  • Stroke Volume
  • Tetrazoles
  • Valsartan

authors with profiles
  • Michael R. Zile